Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
Covington
AstraZeneca
Farmers Insurance
Medtronic
Accenture
US Army
Cipla

Generated: November 15, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Nivolumab

« Back to Dashboard

US Patents for Nivolumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nivolumab ➤ Try a Free Trial Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ➤ Try a Free Trial
Nivolumab ➤ Try a Free Trial Antibody-drug conjugates and immunotoxins Oncomatryx Biopharma, S.L. (Derio, ES) ➤ Try a Free Trial
Nivolumab ➤ Try a Free Trial Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods Biodesix, Inc. (Boulder, CO) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Nivolumab

Drugname Country Document Number Estimated Expiration Related US Patent
Nivolumab European Patent Office 3313818 2035-06-26 ➤ Try a Free Trial
Nivolumab World Intellectual Property Organization (WIPO) 2016210262 2035-06-26 ➤ Try a Free Trial
Nivolumab Canada 2937600 2034-02-06 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
McKesson
Julphar
Johnson and Johnson
Moodys
Baxter
Fish and Richardson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.